Results 21 to 30 of about 1,618,966 (304)

Longitudinal Trajectories of Fasting Plasma Glucose and Risks of Cardiovascular Diseases in Middle Age to Elderly People Within the General Japanese Population: The Suita Study

open access: yesJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2019
Background Few previous studies used information on changes in fasting plasma glucose (FPG) assessed at multiple points in time in relationship to cardiovascular disease (CVD) incidence.
Soshiro Ogata   +11 more
doaj   +1 more source

Multivitamins and minerals modulate whole-body energy metabolism and cerebral blood-flow during cognitive task performance: a double-blind, randomised, placebo-controlled trial [PDF]

open access: yes, 2016
Background: The brain is by far the most metabolically active organ in the body, with overall energy expenditure and local blood-supply closely related to neural activity.
Jackson, Philippa A.   +41 more
core   +1 more source

Dehydration affects cerebral blood flow but not its metabolic rate for oxygen during maximal exercise in trained humans [PDF]

open access: yes, 2014
This article has been made available through the Brunel Open Access Publishing Fund.Key points: Dehydration accrued during exercise in the heat challenges systemic and locomotor muscle blood flow, but its impact on cerebral blood flow (CBF) and ...
Stock, Christopher G   +12 more
core   +1 more source

Using Cerebral Metabolites to Guide Precision Medicine for Subarachnoid Hemorrhage: Lactate and Pyruvate

open access: yesMetabolites, 2019
Subarachnoid hemorrhage (SAH) is one of the deadliest types of strokes with high rates of morbidity and permanent injury. Fluctuations in the levels of cerebral metabolites following SAH can be indicators of brain injury severity.
Kaneez Zahra   +3 more
doaj   +1 more source

The Therapeutic Potential and Limitations of Ketones in Traumatic Brain Injury

open access: yesFrontiers in Neurology, 2021
Traumatic brain injury (TBI) represents a significant health crisis. To date, no FDA approved pharmacotherapies are available to prevent the neurological deficits caused by TBI. As an alternative to pharmacotherapy treatment of TBI, ketones could be used
Savannah Anne Daines   +1 more
doaj   +1 more source

U0126 attenuates cerebral vasoconstriction and improves long-term neurologic outcome after stroke in female rats. [PDF]

open access: yes, 2015
Sex differences are well known in cerebral ischemia and may impact the effect of stroke treatments. In male rats, the MEK1/2 inhibitor U0126 reduces ischemia-induced endothelin type B (ETB) receptor upregulation, infarct size and improves acute ...
Edvinsson, Lars   +14 more
core   +1 more source

THE EFFECT OF PENTOXIFYLLINE ON CEREBRAL METABOLISM.

open access: yes, 1978
THE EFFECT OF PENTOXIFYLLINE ON CEREBRAL ...
RENATA ELIZABETH. BLUHM KOLLER (7972856)
core   +4 more sources

Cerebral Metabolic Analysis of Patients With Colorectal Cancer and Chronic Enteritis: Inquiry Into Gut-Brain Crosstalk

open access: yesFrontiers in Neuroscience, 2022
Gut-brain crosstalk has been demonstrated previously. However, brain metabolic patterns of colorectal cancer and chronic enteritis remain unclear. A better understanding of gut-brain crosstalk from a radiological perspective is necessary.
Jie Ma   +11 more
doaj   +1 more source

Does Endogenous Norepinephrine Regulate Potassium Homeostasis and Metabolism in Rat Cerebral Cortex?

open access: yes, 2016
The role of endogenous cerebral norepinephrine (NE) as a modulator of transmembrane cation transport and energy metabolism was evaluated by monitoring extracellular potassium ion activity ([K+]o) in vivo and by measuring cortical Na+,K+-ATPase activity ...
Rosenthal, Myron   +5 more
core   +2 more sources

Glucagon-like Peptide-1 analogues and delipidation of coronary atheroma in statin-treated type 2 diabetic patients with coronary artery disease: The prespecified sub-analysis of the OPTIMAL randomized clinical trial

open access: yesAtherosclerosis Plus
Background and aims: Randomized clinical trials have demonstrated the ability of glucagon-like peptide-1 analogues (GLP-1RAs) to reduce atherosclerotic cardiovascular disease events in patients with type 2 diabetes (T2D).
Yu Kataoka   +27 more
doaj   +1 more source

Home - About - Disclaimer - Privacy